Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis
Clinical Question: What are the benefits and harms of perioperative pharmacological thromboprophylaxis in cancer patients undergoing surgery?
Reduced doses maintain effectiveness; still more effective than aspirin.
Has the more widespread use of antithrombotic medication resulted in more cases of subdural hemotoma?
Clinical question: Is therapeutic anticoagulation superior to placebo in patients with symptomatic acute calf deep venous thrombosis (DVT)?
Evidence suggests fondaparinux is more effective than LMWH in prevention of VTE and total DVT in the postoperative setting
Clinical question: How do pentasaccharides compare to other anticoagulants in postoperative venous thromboembolism prevention?
Clinical question: What is the prevalence of acute pulmonary emboli (PE) in patients admitted for syncope?
Clinical question: Is DVT prophylaxis necessary with lower leg casting or after knee arthroscopy?
Clinical question: Is the risk of recurrence for a venous thromboembolism (VTE) acquired as an inpatient higher than other reversible risk factors...
SAN DIEGO - Rising rates of pediatric venous thromboembolism in the United States underscore the need to carefully weigh the risks and benefits of...